These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32122645)

  • 21. Neonatal S100B protein levels after prenatal exposure to selective serotonin reuptake inhibitors.
    Pawluski JL; Galea LA; Brain U; Papsdorf M; Oberlander TF
    Pediatrics; 2009 Oct; 124(4):e662-70. PubMed ID: 19786426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative data.
    Singal D; Brownell M; Chateau D; Ruth C; Katz LY
    BMJ Open; 2016 Nov; 6(11):e013293. PubMed ID: 27899401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.
    Gur TL; Kim DR; Epperson CN
    Psychopharmacology (Berl); 2013 Jun; 227(4):567-82. PubMed ID: 23681158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence.
    Alwan S; Friedman JM; Chambers C
    CNS Drugs; 2016 Jun; 30(6):499-515. PubMed ID: 27138915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
    van der Veere CN; Bos AF
    Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2873-4. PubMed ID: 18257430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy.
    Engelstad HJ; Roghair RD; Calarge CA; Colaizy TT; Stuart S; Haskell SE
    Neonatology; 2014; 105(2):149-54. PubMed ID: 24356332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoxetine during pregnancy: impact on fetal development.
    Morrison JL; Riggs KW; Rurak DW
    Reprod Fertil Dev; 2005; 17(6):641-50. PubMed ID: 16263070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.
    Colvin L; Slack-Smith L; Stanley FJ; Bower C
    CNS Drugs; 2012 Jul; 26(7):e1-14. PubMed ID: 22712699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal use of SSRIs, SNRIs and NaSSAs: practical recommendations during pregnancy and lactation.
    Sie SD; Wennink JM; van Driel JJ; te Winkel AG; Boer K; Casteelen G; van Weissenbruch MM
    Arch Dis Child Fetal Neonatal Ed; 2012 Nov; 97(6):F472-6. PubMed ID: 23080479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.
    Cantor Sackett J; Weller RA; Weller EB
    Curr Psychiatry Rep; 2009 Jun; 11(3):253-7. PubMed ID: 19470288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of age.
    Weikum WM; Mayes LC; Grunau RE; Brain U; Oberlander TF
    Infant Behav Dev; 2013 Dec; 36(4):485-93. PubMed ID: 23728194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal SSRI exposure alters neonatal corticosteroid binding globulin, infant cortisol levels, and emerging HPA function.
    Pawluski JL; Brain UM; Underhill CM; Hammond GL; Oberlander TF
    Psychoneuroendocrinology; 2012 Jul; 37(7):1019-28. PubMed ID: 22177580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does fetal exposure to SSRIs or maternal depression impact infant growth?
    Wisner KL; Bogen DL; Sit D; McShea M; Hughes C; Rizzo D; Confer A; Luther J; Eng H; Wisniewski SW
    Am J Psychiatry; 2013 May; 170(5):485-93. PubMed ID: 23511234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.
    Gentile S
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1585-97. PubMed ID: 26135630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SSRI antidepressants and persistent pulmonary hypertension in newborns.
    Prescrire Int; 2008 Aug; 17(96):156. PubMed ID: 19492488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current evaluation of teratogenic and fetotoxic effects of psychotropic drugs].
    Watanabe O
    Seishin Shinkeigaku Zasshi; 2014; 116(12):996-1004. PubMed ID: 25823351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A meta-analysis of selective serotonin reuptake inhibitors (SSRIs) use during prenatal depression and risk of low birth weight and small for gestational age.
    Zhao X; Liu Q; Cao S; Pang J; Zhang H; Feng T; Deng Y; Yao J; Li H
    J Affect Disord; 2018 Dec; 241():563-570. PubMed ID: 30153640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats.
    Glover ME; Pugh PC; Jackson NL; Cohen JL; Fant AD; Akil H; Clinton SM
    Neuroscience; 2015 Jan; 284():775-797. PubMed ID: 25451292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antenatal depression and antidepressants during pregnancy: unraveling the complex interactions for the offspring.
    Olivier JD; Åkerud H; Sundström Poromaa I
    Eur J Pharmacol; 2015 Apr; 753():257-62. PubMed ID: 25094036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective serotonin reuptake inhibitors in pregnancy.
    Bellissima V; Ververs TF; Visser GH; Gazzolo D
    Curr Med Chem; 2012; 19(27):4554-61. PubMed ID: 22876893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.